Australian Pharma Stock News

Insiders who bought Atomo Diagnostics Limited ( ASX:AT1 ) stock in the last 12 months were richly rewarded last week...

Zoono Group Limited ( ASX:ZNO ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

Last week, TerraCom Limited ( ASX:TER ) insiders, who had purchased shares in the previous 12 months were rewarded...

Macquarie Technology Group's (ASX:MAQ) stock is up by a considerable 11% over the past three months. Since the market...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Life360, Inc. ( ASX:360 ), is not the largest company out there, but it saw significant share price movement during...

Life360, Inc. ( ASX:360 ) shares have had a horrible month, losing 27% after a relatively good period beforehand...

COSOL Limited ( ASX:COS ) shareholders should be happy to see the share price up 22% in the last week. But that is...

Ampol Limited's ( ASX:ALD ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a strong buy right now...

Bellevue Gold (ASX:BGL) has confirmed it is back on track at Deacon North, resuming development and keeping first ore from this high grade zone pencilled in for the June 2026 quarter. See our latest analysis for Bellevue Gold. Investors seem to be leaning into that higher grade outlook, with the share price at A$1.425 driving a 22.84 percent 1 month share price return and a 62.86 percent 3 month share price return. The 3 year total shareholder return of 33.8 percent shows momentum has been...

APA Group (ASX:APA) has drawn fresh attention after signing a joint development agreement with CS Energy to lead and own 80% of the proposed 400MW Brigalow Peaking Power Plant in Queensland. See our latest analysis for APA Group. The Brigalow announcement lands after a busy stretch for APA, including the sale of its Networks business. It comes with the share price at A$9.29 after a robust year to date share price return of 32.34 percent and a strong 1 year total shareholder return of 40.33...

Telix Pharmaceuticals (ASX:TLX) just released ZIRCON-X study data showing its TLX250-CDx kidney imaging agent could have changed clinical decisions for almost half of patients, with more than 20% potentially avoiding invasive biopsy. See our latest analysis for Telix Pharmaceuticals. Despite the latest ZIRCON-X update highlighting the potential commercial impact of TLX250-CDx, Telix’s recent share price performance has been choppy, with a 1 month share price return of minus 9.68 percent and a...

When you see that almost half of the companies in the Telecom industry in Australia have price-to-sales ratios (or...

Some Mayfield Group Holdings Limited ( ASX:MYG ) shareholders may be a little concerned to see that the Non-Executive...

Insiders who bought XPON Technologies Group Limited ( ASX:XPN ) stock lover the last 12 months are probably not as...

Brookside Energy Limited ( ASX:BRK ) shares have continued their recent momentum with a 29% gain in the last month...

Downer EDI Limited ( ASX:DOW ), is not the largest company out there, but it saw a decent share price growth of 15% on...

We'd be surprised if Capral Limited ( ASX:CAA ) shareholders haven't noticed that the MD, CEO & Non Independent...

With the business potentially at an important milestone, we thought we'd take a closer look at Betmakers Technology...

Some Energy One Limited ( ASX:EOL ) shareholders may be a little concerned to see that the Independent Non-Executive...

Genesis Minerals (ASX:GMD) just stepped into the spotlight at the Resources Rising Stars Summer Series in Sydney, where Corporate Development Officer Troy Irvin outlined how the gold producer is thinking about growth and capital allocation. See our latest analysis for Genesis Minerals. The timing of Irvin’s update lines up with a strong run in the stock, with a 30 day share price return of 15.61 percent feeding into a hefty year to date share price gain and a three year total shareholder...

As the Australian market navigates a turbulent landscape marked by mixed GDP data and volatile sector performances, investors are keenly observing growth companies that demonstrate resilience and potential. In such an environment, stocks with high insider ownership often signal confidence from those who know the company best, making them attractive prospects for those seeking stability amid uncertainty.

The Australian market has recently experienced a rollercoaster of activity, with the ASX200 showing volatility in response to weaker-than-expected GDP data, reflecting divided investor sentiment. In such fluctuating conditions, identifying stocks with strong fundamentals becomes crucial for investors seeking stability and potential growth. Penny stocks, despite their outdated connotation, continue to represent smaller or emerging companies that can offer significant value when backed by...

South32 Limited has appointed Geoff Healy as an independent Non-Executive Director, with his Board tenure beginning on 2 December 2025 and formal election to be sought at the 2026 Annual General Meeting. His background in climate, sustainability, legal and external affairs across BCG, BHP and Herbert Smith Freehills suggests a stronger emphasis on risk, ESG and energy-transition governance within South32’s boardroom. We’ll now examine how Healy’s ESG-focused appointment could reshape...